About
Basic Data Updated:
4 days agoEmbio Limited, formerly known as Emmellen Biotech Pharmaceuticals Ltd, has been involved in the production and promotion of Active Pharmaceutical Ingredients (APIs) and intermediates for both the international and domestic markets. The company has a specialization in Ephedrine/ Pseudoephedrine and Chiral products. These products have a wide range of applications, with Ephedrine/ Pseudoephedrine being primarily used as a decongestant in cold and cough medicines, while Chiral Intermediates are utilized in the production of anti-HIV and anti-obesity drugs. In addition to these products, Embio Limited has also been expanding its focus on animal health care products. These products are used as feed additives to increase the fat content in pigs, cattle, turkeys, and hens that are raised for th... Read More
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U24110MH1986PLC038680 |
| Company No. | 038680 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 20 Jan 1986 |
| Date of AGM | 07 Aug 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Mumbai |
Products or Services related to Embio Limited
Product Development Research
Financials of Embio Limited
Embio Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 15.19% decrease. The company also saw a substantial fall in profitability, with a 87.83% decrease in profit. The company's net worth dipped by a decrease of 0.18%.
Enhance accessibility to Embio's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Embio's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Embio Limited
Unlock and access historical data on people associated with Embio, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
Rajendra Kamalakant
CFOAppointment Date: 06-Jun-2014
Status: Current
DM
Devesh Malladi Managing DirectorAppointment Date: 01-Oct-2007
Status: Current
GN
Ganesh Nalawade Company SecretaryAppointment Date: 13-Feb-2017
Status: Current
Board Members(4)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 07 Mar 2022 | ₹25.00 Cr | Open |
Biotechnology Industry Research Assistance Council Creation Date: 10 Dec 2012 | ₹2.00 Cr | Open |
Axis Bank Limited Creation Date: 03 Dec 2002 | ₹25.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Embio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Embio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
61 years 1 month 
Recent activity within the organization
Annual General Meeting
Embio Limited last Annual general meeting of members was held on 07 Aug 2023 as per latest MCA records.
07 Aug 2023Balance Sheet
Embio Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge with Axis Bank Limited of Rs. 25.00 cr registered on 07 Mar 2022 with Charge ID 100554671 was modified on 08 Sep 2022.
08 Sep 2022Charges
A charge with Axis Bank Limited of Rs. 25.00 cr registered on 03 Dec 2002 with Charge ID 80046613 was modified on 08 Sep 2022.
08 Sep 2022Charges
A charge with Axis Bank Limited amounted to Rs. 25.00 cr with Charge ID 100554671 was registered on 07 Mar 2022.
07 Mar 2022
Frequently asked questions
What is the Incorporation or founding date of Embio Limited?
